Top Biotechnology companies in Canada by EBITDA

This ranking features the top 26 Biotechnology companies in Canada ranked by EBITDA, totalling a EBITDA of USD -1.17 B, for January 15, 2025.
#
Name
EBITDA
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 2.60 M
Dec. 31, 2023 USD 2.08 1.92%

Canada

2
USD -2.75 M
March 31, 2024 USD 1.82 -9.45%

Canada

3
USD -3.09 M
Dec. 31, 2023 USD 2.66 14.16%

Canada

4
USD -3.24 M
Dec. 31, 2023 USD 2.88 1.69%

Canada

5
USD -3.82 M
Dec. 31, 2023 USD 2.82 -2.42%

Canada

6
USD -6.13 M
Sept. 30, 2024 USD 1.59 -8.09%

Canada

7
USD -6.47 M
Dec. 31, 2023 USD 1.25 -0.34%

Canada

8
USD -7.26 M
Nov. 30, 2024 USD 1.93 -6.31%

Canada

9
USD -9.86 M
Nov. 30, 2023 USD 1.71 4.46%

Canada

10
USD -10.40 M
Dec. 31, 2023 USD 0.11 0.09%

Canada

11
USD -13.37 M
Dec. 31, 2023 USD 2.12 -1.09%

Canada

12
USD -13.78 M
March 31, 2024 USD 0.91 -2.78%

Canada

13
USD -21.04 M
Dec. 31, 2023 USD 1.25 -1.98%

Canada

14
USD -25.43 M
Dec. 31, 2023 USD 0.82 -3.10%

Canada

15
USD -26.73 M
Dec. 31, 2023 USD 3.15 -5.12%

Canada

16
USD -28.21 M
Dec. 31, 2023 USD 3.02 1.15%

Canada

17
USD -28.45 M
Sept. 30, 2024 USD 1.77 2.31%

Canada

18
USD -52.04 M
Oct. 31, 2024 USD 7.58 -5.96%

Canada

19
USD -56.84 M
Dec. 31, 2023 USD 1.96 -0.51%

Canada

20
USD -58.00 M
March 31, 2024 USD 8.83 -0.79%

Canada

21
USD -63.05 M
Dec. 31, 2023 USD 7.55 -2.83%

Canada

22
USD -92.57 M
Dec. 31, 2023 USD 6.40 -1.54%

Canada

23
USD -114.27 M
Dec. 31, 2023 USD 1.27 -3.05%

Canada

24
USD -120.70 M
Dec. 31, 2023 USD 13.62 -2.44%

Canada

25
USD -192.16 M
Dec. 31, 2023 USD 2.77 -7.67%

Canada

26
USD -210.51 M
Dec. 31, 2023 USD 39.65 3.66%

Canada

Frequently Asked Questions
  • Which Biotechnology company in Canada has the highest EBITDA ?

    The Biotechnology company in Canada with the highest EBITDA is BioRem Inc. (TSXV: BRM.V) at USD 2.60 M.

  • Which Biotechnology company in Canada has the lowest EBITDA ?

    The Biotechnology company in Canada with the lowest EBITDA is Xenon Pharmaceuticals Inc. (NasdaqGM: XENE) at USD -210.51 M.